ACLARIS THERAPEUTICS INC (ACRS) Stock Cash Flow
NASDAQ:ACRS - Nasdaq - US00461U1051 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.00M | -88.48M | -86.91M | -90.87M | -51.02M | |||
| Depreciation Amortization | 887.00K | 863.00K | 800.00K | 920.00K | 1.32M | |||
| Income Taxes - Deferred | N/A | -367.00K | N/A | 0.00 | -180.00K | |||
| Change In Working Capital | 25.20M | 9.39M | -1.20M | -1.34M | -2.36M | |||
| Other non cash items | -6.61M | 271.00K | 19.74M | 39.15M | 13.60M | |||
| OPERATING CASH FLOW | -17.90M | -78.33M | -67.57M | -52.13M | -38.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -560.00K | -1.31M | -610.00K | -310.00K | -450.00K | |||
| Other Investing Activity | 27.06M | 47.53M | 13.23M | -167.32M | 6.84M | |||
| INVESTING CASH FLOW | 26.50M | 46.22M | 12.63M | -167.63M | 6.39M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -11.48M | 10.78M | |||
| Stock Issued/Repurchased | N/A | 26.81M | 72.90M | 239.66M | 7.81M | |||
| Other Financing Activity | -78.00K | -102.00K | -30.00K | -3.12M | -210.00K | |||
| FINANCING CASH FLOW | 2.00K | 26.71M | 72.87M | 225.05M | 18.37M | |||
| CHANGE IN CASH | 8.60M | -5.40M | 17.93M | 5.29M | -13.87M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.90M | -78.33M | -67.57M | -52.13M | -38.63M | |||
| Capital Expenditure | -560.00K | -1.31M | -610.00K | -310.00K | -450.00K | |||
| FREE CASH FLOW | -18.46M | -79.63M | -68.18M | -52.44M | -39.08M | |||
All data in USD